John Boozman's BSX trades
- The latest BSX trade was a sale on Jun 4, 2026, when BSX closed at $48.85. It closed at $44.35 on Nov 13, 2026 (-9%).
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
John Boozman reported 3 BSX transactions in 3 filings with the Senate eFD for 2025–2026: 1 purchase and 2 sales of Boston Scientific Corporation, with trade dates from Feb 13, 2025 to Jun 4, 2026. The median gap between trade date and filing date is 27 days, and every trade was reported within 45 days.
- 3
- 1 / 2
- $3K to $45K
- 2026-07-13
BSX transactions reported by John Boozman
| Type | Owner | ||||
|---|---|---|---|---|---|
Boston Scientific Corporation Common Stock BSX | Sale | Joint | $1,001 - $15,000 | 2026-07-13 #c52854ed-a778-483a-883c-0ba2bba17877 | |
Boston Scientific Corp BSX | Sale | Joint | $1,001 - $15,000 | 2026-01-13 #d3daa40b-123d-4451-9974-02bf5a96d8da | |
Boston Scientific Corp BSX | Purchase | Joint | $1,001 - $15,000 | 2025-03-06 #6cf4a78e-92f0-4201-bf73-e9b02cd8f9ef |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 3 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 2
- 31–45 days
- 1
- Over 45 days
- 0
- Median / longest
- 27d / 39d
Source documents
3 Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #c52854ed-a778-483a-883c-0ba2bba17877Filed 2026-07-13 · 1 row
- #d3daa40b-123d-4451-9974-02bf5a96d8daFiled 2026-01-13 · 1 row
- #6cf4a78e-92f0-4201-bf73-e9b02cd8f9efFiled 2025-03-06 · 1 row
What John Boozman's BSX filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Boston Scientific Corporation financials and filings
Audited SEC figures, what moves BSX, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Issue 07: The Vote That Knocked Almost a Quarter off Data Center Stocks
Texas has frozen new data center approvals since the summer. The vote extends that freeze, but it cannot unplug campuses that already have power. We map who is exposed, test whether the sell-off overshot and say where the real risk sits.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchOther members of Congress who reported BSX
More tickers reported by John Boozman
John Boozman and BSX: questions
Did John Boozman buy or sell BSX?
Senate eFD filings for 2025 and 2026 show 1 purchase and 2 sales of Boston Scientific Corporation (BSX) reported by John Boozman, between 2025-02-13 and 2026-06-04. Reported owner: Joint.
How much BSX did John Boozman trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K to $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last BSX filing by John Boozman?
The most recent filing that includes a BSX trade was filed on 2026-07-13. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Boston Scientific Corporation. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
John Boozman BSX disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included